Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Role of oral medications in spasticity management.

Watanabe TK.

PM R. 2009 Sep;1(9):839-41. doi: 10.1016/j.pmrj.2009.07.014. Review.

PMID:
19769918
2.

Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.

Chou R, Peterson K, Helfand M.

J Pain Symptom Manage. 2004 Aug;28(2):140-75. Review.

PMID:
15276195
3.

[Orally administered drugs in the treatment of spasticity].

Campistol J.

Rev Neurol. 2003 Jul 1-15;37(1):70-4. Review. Spanish.

4.

Pharmacotherapy of spasticity in children with cerebral palsy.

Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P.

Pediatr Neurol. 2006 Jan;34(1):1-6. Review.

PMID:
16376270
5.

[Medical treatment of spasticity].

Rode G, Maupas E, Luaute J, Courtois-Jacquin S, Boisson D.

Neurochirurgie. 2003 May;49(2-3 Pt 2):247-55. Review. French.

PMID:
12746699
6.

Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.

Rietman JS, Geertzen JH.

Acta Neurochir Suppl. 2007;97(Pt 1):205-11. Review.

PMID:
17691378
7.

Tizanidine for spasticity.

[No authors listed]

Med Lett Drugs Ther. 1997 Jul 4;39(1004):62-3. No abstract available.

PMID:
9217694
8.

Anti-spasticity medications.

Al-Shahrani AM.

Saudi Med J. 2003 Jan;24(1):19-22. Review.

PMID:
12590267
9.

The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics.

Segatore M, Miller M.

SCI Nurs. 1995 Mar;12(1):2-7. Review.

PMID:
7792578
10.

Approach to the rehabilitation of spasticity and neuromuscular disorders in children.

Tilton AH.

Neurol Clin. 2003 Nov;21(4):853-81, vii. Review.

PMID:
14743653
11.

Botulinum toxin for the management of adult patients with upper motor neuron syndrome.

Esquenazi A, Mayer NH, Elia AE, Albanese A.

Toxicon. 2009 Oct;54(5):634-8. doi: 10.1016/j.toxicon.2009.01.022.

PMID:
19470335
12.

Antispasticity medications.

Nance PW, Young RR.

Phys Med Rehabil Clin N Am. 1999 May;10(2):337-55, viii. Review.

PMID:
10370935
13.

Muscle relaxants and antispasticity agents.

Meleger AL.

Phys Med Rehabil Clin N Am. 2006 May;17(2):401-13. Review.

PMID:
16616274
14.

[Clinical evaluation of spasticity].

Ben Smaïl D, Kiefer C, Bussel B.

Neurochirurgie. 2003 May;49(2-3 Pt 2):190-8. Review. French.

PMID:
12746693
15.
16.

Alpha adrenergic and serotonergic agents in the treatment of spastic hypertonia.

Nance PW.

Phys Med Rehabil Clin N Am. 2001 Nov;12(4):889-905. Review.

PMID:
11723869
17.

[Management of spasticity in children with cerebral palsy].

Matthews DJ, Balaban B.

Acta Orthop Traumatol Turc. 2009 Mar-Apr;43(2):81-6. doi: 10.3944/AOTT.2009.081. Turkish.

18.

Management of spasticity in children with cerebral palsy.

Tilton A.

Semin Pediatr Neurol. 2009 Jun;16(2):82-9. doi: 10.1016/j.spen.2009.03.006. Review.

PMID:
19501336
19.

[Physical and other methods therapy of the spasticity in children].

Swierczyńska A, Renata K, Jaworek M.

Przegl Lek. 2007;64(11):974-7. Review. Polish.

PMID:
18409416
20.

Acute care management of post-TBI spasticity.

Zafonte R, Elovic EP, Lombard L.

J Head Trauma Rehabil. 2004 Mar-Apr;19(2):89-100. Review.

PMID:
15247820
Items per page

Supplemental Content

Support Center